“…The current literature refers to palliative sedation as terminal sedation and has focused on defining it, determining how often refractory symptoms occur in patients with advanced cancer, and discussion of the types of medications used to induce sedation (Chater, et a1., 1998;Cherny & Portenoy, !994;Fainsinger, Miller, Bruera, Hanson & Maceachern, 1991;Green & Davis, 1991; Morita, Inoue & Chihara, 1996; stone, Phillips, spruyt & waight, 1997;Ventafridda, Ripamonti, Deconno, Tamburini & Cassileth, 1990 (Bonica, 1985;Daut & Cleeland , lg82 (Bruera, Chadwick, Weinlick & Macdonald, 1987;Lawlor, Fainsinger, Bruera, 2000;Massie, Holland & Glass, 1983). Furthermore, in a canadian survey ofcancer patients (n:913), 94 % ofrespondents reported L 4 experiencing more than one symptom (Ashbury,Findlay,Reynolds & McKerracher,1g98).…”